Abstract:Effective and accurate diagnosis of Alzheimer's disease (AD), as well as its prodromal stage (i.e., mild cognitive impairment (MCI)), has attracted more and more attention recently. So far, multiple biomarkers have been shown to be sensitive to the diagnosis of AD and MCI, i.e., structural MR imaging (MRI) for brain atrophy measurement, functional imaging (e.g., FDG-PET) for hypometabolism quantification, and cerebrospinal fluid (CSF) for quantification of specific proteins. However, most existing research focuses on only a single modality of biomarkers for diagnosis of AD and MCI, although recent studies have shown that different biomarkers may provide complementary information for the diagnosis of AD and MCI. In this paper, we propose to combine three modalities of biomarkers, i.e., MRI, FDG-PET, and CSF biomarkers, to discriminate between AD (or MCI) and healthy controls, using a kernel combination method. Specifically, ADNI baseline MRI, FDG-PET, and CSF data from 51AD patients, 99 MCI patients (including 43 MCI converters who had converted to AD within 18 months and 56 MCI non-converters who had not converted to AD within 18 months), and 52 healthy controls are used for development and validation of our proposed multimodal classification method. In particular, for each MR or FDG-PET image, 93 volumetric features are extracted from the 93 regions of interest (ROIs), automatically labeled by an atlas warping algorithm. For CSF biomarkers, their original values are directly used as features. Then, a linear support vector machine (SVM) is adopted to evaluate the classification accuracy, using a 10-fold cross-validation. As a result, for classifying AD from healthy controls, we achieve a classification accuracy of 93.2% (with a sensitivity of 93% and a specificity of 93.3%) when combining all three modalities of biomarkers, and only 86.5% when using even the best individual modality of biomarkers. Similarly, for classifying MCI from healthy controls, we achieve a classification accuracy of 76.4% (with a sensitivity of 81.8% and a specificity of 66%) for our combined method, and only 72% even using the best individual modality of biomarkers. Further analysis on MCI sensitivity of our combined method indicates that 91.5% of MCI converters and 73.4% of MCI non-converters are correctly classified. Moreover, we also evaluate the classification performance when employing a feature selection method to select the most discriminative MR and FDG-PET features. Again, our combined method shows considerably better performance, compared to the case of using an individual modality of biomarkers.

Improving the Classification Performance of Amnestic MCI Using Multiple Neuropsychological Scales

Classification and Interpretability of Mild Cognitive Impairment Based on Resting-State Functional Magnetic Resonance and Ensemble Learning.

Towards Effective Classification of Amci Based on Resting-State Multiscale Brain Features and Machine Learning Approaches

Multiple Connection Pattern Combination from Single-Mode Data for Mild Cognitive Impairment Identification

Enhancing the Feature Representation of Multi-Modal MRI Data by Combining Multi-View Information for MCI Classification

Multimodal classification of Alzheimer's disease and mild cognitive impairment

Combined Support Vector Machine Classifier and Brain Structural Network Features for the Individual Classification of Amnestic Mild Cognitive Impairment and Subjective Cognitive Decline Patients

Improving Alzheimer's Disease Classification by Combining Multiple Measures

Multi-Modal Feature Selection with Feature Correlation and Feature Structure Fusion for MCI and AD Classification

Neural Mechanism Underlying Successful Classification of Amnestic Mild Cognitive Impairment Using Multi-Sensory-Evoked Potentials

Identification of MCI individuals using structural and functional connectivity networks

Study on the Feasibility of Using a Chinese Character Writing Scale to Distinguish Amnestic-MCI

A Multi-Modal and Multi-Atlas Integrated Framework for Identification of Mild Cognitive Impairment

Classifying MCI Subtypes in Community-Dwelling Elderly Using Cross-Sectional and Longitudinal MRI-Based Biomarkers.

Multimodal Classification of Mild Cognitive Impairment Based on Partial Least Squares

Classification Study of Mild Cognitive Impairment Based on Multi-feature Fusion for Cortical Morphology

Identifying Mild Cognitive Impairment with Random Forest by Integrating Multiple MRI Morphological Metrics

Classification of MRI and Psychological Testing Data Based on Support Vector Machine.

A Hierarchical Model For Identifying Mild Cognitive Impairment

Identifying Alzheimer's disease and mild cognitive impairment with atlas-based multi-modal metrics

Multi-scale Features Extraction from Baseline Structure MRI for MCI Patient Classification and AD Early Diagnosis